GGrantIndex
Sort

8,912 grants matching sars cov 2

GENES AND MICROBES: NGSS-ALIGNED CURRICULA FOR SECONDARY SCIENCE

$54,000
Louisa A Stark · University Of Utah · R25 · FY2021 · GM

Drug Discovery and Biomedical Research Training (DDBRT) Program for Underserved Minority Youth

$54,000
Adel Karara · University Of Maryland Eastern Shore · R25 · FY2021 · GM

ACR Basic and Clinical Research Conference: Rheumatologic Complications of Emerging Viral Infections / SARS-CoV-2

$54,000
Kristine A. Kuhn · American College Of Rheumatology · U13 · FY2021 · AR

Encouraging Excellence: Health Science Education in Native American Communities

$53,999
Maurice Godfrey · University Of Nebraska Medical Center · R25 · FY2021 · GM

One Health Education: Connecting Humans, Animals, and the Environment

$53,996
Dina Grossman Markowitz · University Of Rochester · R25 · FY2021 · GM

Investigating the redox-sensitive E3 ubiquitin ligase Pellino-1 as a driver of T-cell dysfunction during severe lung infection

$53,974
Tiffany Rebecca Merlinsky · Weill Medical Coll Of Cornell Univ · F30 · FY2024 · HL

Protective lung memory B cell functions and dynamics during respiratory infection

$53,974
Neelou Etesami · Boston University Medical Campus · F30 · FY2024 · HL

Advancing our knowledge of viral membrane fusion and of IDP-membrane interactions by ESR

$53,934
Jack H Freed · Cornell University · R35 · FY2023 · GM

Antibody Profiles and Genetics of Pernio-Like Lesions during the COVID-19 pandemic

$53,860
Esther E Freeman · Massachusetts General Hospital · K23 · FY2021 · AI

Molecular pathogenesis of human coronaviruses

$53,709
Marshall Bloom · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

The Science of COVID-19 Vaccines

$53,568
Tim M. Herman · Milwaukee School Of Engineering · R25 · FY2021 · GM

K-12 Educational Resources on Vaccine Biology and SARS-CoV-2 Vaccine Hesitancy

$53,536
Julie Harlin · Texas A&M Agrilife Research · R25 · FY2021 · GM

Partnerships for Prevention: A plan for managing student stress, anxiety, and pain through interactive media.

$53,379
John Archie Pollock · Duquesne University · R25 · FY2021 · GM

RAPID: Collaborative Research: Metapopulation Modeling to Develop Strategies to Reduce COVID-19 Transmission in Public Spaces

$53,288
Davida S Smyth · The New School · · FY2020 · BIO

Deciphering the Role of the Coronavirus Macro Domain in SARS-CoV Infection

$53,282
Anthony R Fehr · University Of Iowa · F32 · FY2014 · AI

RAPID: Collaborative Research: COVID-19, human milk and infant feeding

$53,163
Courtney L Meehan · Washington State University · · FY2020 · BIO

Vet-LIRN Network Capacity Building for SARS-CoV-2: equipment for analysis of NGS library and data

$52,822
Leyi Wang · University Of Illinois At Urbana-Champaign · U18 · FY2023 · FD

Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study

$52,799
Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH

Protective lung memory B cell functions and dynamics during respiratory infection

$52,694
Neelou Etesami · Boston University Medical Campus · F30 · FY2023 · HL

Antiviral innate immune responses to pathogenic coronaviruses in the nasal epithelium

$52,694
Clayton Otter · University Of Pennsylvania · F30 · FY2023 · AI

Longitudinal mucosal immune response to SARS-CoV-2 starting prior to infection

$52,694
Alexander Viloria Winnett · California Institute Of Technology · F30 · FY2023 · AI

Epitope focusing using structure-based immunogen design approaches

$52,694
Blake Marie Hauser · Harvard Medical School · F30 · FY2023 · AI

Enhancing K-12 School Safety During a Respiratory Viral Pandemic

$52,694
Dan Li · Yale University · F30 · FY2024 · HD

Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections

$52,406
Jeanne Sisk · University Of Maryland Baltimore · F32 · FY2015 · AI

Harnessing the power of extracellular matrix to treat COVID-19 ARDS

$52,290
Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES